NHICU — NewHold Investment Corp. III

Nasdaq · Financials · Diversified Financial Services · CIK 2043699 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease, a mobile application that provides users access to medical imaging results; and Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 0 -1,150,000 704,000 211,869,000 624,000 8,906,000
Dec 2025 0 -1,293,000 726,000 210,554,000 1,198,000 8,295,000
Sep 2025 0 -261,000 1,911,000 208,786,000 1,389,000 7,253,000
Jun 2025 0 -269,000 1,888,000 206,856,000 1,567,000 7,234,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-1,138,000
Investing CF
$0
Financing CF
$0
CapEx
Dividends Paid
Buybacks
EPS Diluted TTM
As of
2026-06-07

Balance + Analyst (yfinance extras)

Retained Earnings
$-8,105,000
Inventory
Receivables
ST Investments
EBIT TTM
$-2,973,000
Pretax Income TTM
$5,229,000
Interest Exp TTM
Analysts

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 0 -2,090,000 4,918,000 210,554,000 8,295,000 -1,006,000
Dec 2024 382,000 447,000

Peers — same industry

TickerNameMarket CapLastDaily %
HASI HA Sustainable Infrastructure Capital, Inc. $4.83B $37.82
CCXI Churchill Capital Corp XI $651.55M $15.55
DMII Drugs Made In America Acquisition II Corp. $643.37M $10.10
BCSS Bain Capital GSS Investment Corp. $480.96M $10.26
EVAC EQV Ventures Acquisition Corp. II $479.34M $10.21

News headlines (Yahoo Finance, 1h cache)

NewHold Investment Corp. III and newcleo Ltd. Announce Filing of Registration Statement on Form F-4 with the SEC in Connection With Proposed Business Combination
2026-07-07 20:05 · Yahoo
newcleo Strengthens U.S. Leadership Team with Strategic Appointments of Dustin Greenwood and Travis Chapman
2026-06-11 12:00 · Yahoo
Newcleo to Go Public in US Through SPAC Merger With NewHold Investment
2026-05-27 12:02 · Yahoo
newcleo, A Developer of Advanced Nuclear Reactors and Nuclear Fuel, to Become Public Company Through Business Combination with NewHold Investment Corp III
2026-05-27 11:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.